Increasing consolidation in laboratories and hospitals in the wake of health care reform to curb healthcare expenses should stimulate the industry growth. Rising number of centralized laboratories and large reference labs should escalate the demand for automated immunoassay analyzer systems.
Adoption of innovative diagnostic technologies should lead to prolific growth in automated immunoassay analyzers market. New product launches with ability to perform more than one test at a time using software allows diagnostic laboratories to perform routine as well as specialized tests.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1727
Stringent regulatory framework and need to operate under rising pricing pressures adversely impacts the profit margins for the laboratories inhibiting the business growth. Laboratories are focusing on high volume testing to improve profitability per test and adopt automated systems to provide accurate diagnosis with effective workflow solutions.
Chemiluminescence analyzers should witness robust growth owing to the sensitivity and accuracy of diagnosis using low analyte concentrations. The automated chemiluminescent immunoassay analyzers improve the work efficiency by identifying over hundreds of analytes per hour.
Infectious diseases should witness a healthy growth to surpass USD 7 billion by 2024. Rising incidence of infectious diseases, growing elderly population and improved healthcare systems is set to drive segment growth.
U.S. automated immunoassay analyzers market accounted for more than 90% of regional industry revenue in 2016. Favorable healthcare reforms for diagnostic care, adoption of innovative products and increasing consolidation of laboratories should boost demand for automated instruments used for high volume testing.
India should witness robust regional growth over forecast years owing to increasing government focus towards development of healthcare infrastructure by encouraging public private partnership to improve healthcare delivery into rural markets. Furthermore, increasing number of pathology laboratories and rising number of private and public hospitals should fuel automated immunoassay analyzers market growth.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1727
Some of the prominent industry players in the competitive market include Abbott Diagnostics, Biokit, Carolina Liquid Chemistries Corporation, Luminex Corporation, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare.
The automated immunoassay analyzers market is dominated by few companies with a strong financial muscle, expanded geographical footprint, and extensive product portfolio. New product launch or customizing existing product by adding broad assay of test menus is the major trend adopted by industry participants to hold their market position.
Automated immunoassay analyzers market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2013 to 2024, for the following segments:
Automated Immunoassay Analyzers Market by Product
- Enzyme Linked Fluorescent System
- Multiplexed Assay System
Automated Immunoassay Analyzers Market by Application
- Infectious Diseases
- Drug Monitoring
- Allergy Testing
Automated Immunoassay Analyzers Market by End-use
- Diagnostic Laboratories
- Research and Academic Laboratories
- Pharmaceutical & Biotechnology Companies
The above information is provided for the following regions/countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia